Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 22 Jul, 01:30 am
International Business Machines Corporation (NYSE: IBM) is under a securities fraud investigation following a significant 25% stock drop. Jefferies analyst Brent Thill set a new price target of $260.00 for IBM, indicating a potential 22.07% increase. Despite the investigation, IB
Intel (NASDAQ: INTC) faces high volatility expectations for its upcoming earnings, significantly more than other major tech companies. RBC Capital maintains a "Sector Perform" rating, suggesting a cautious approach despite healthy core business trends for the semiconductor giant
Earnings Beat: AGNC Investment Corp. surpassed analyst estimates with an earnings per share (EPS) of $0.52 . Revenue Miss: The company's revenue of $1.01 billion fell short of expectations, continuing a recent trend. Challenging Environment: The CEO highlighted geopolitical tensi
Wintrust Financial Corporation (NASDAQ:WTFC) Delivers Strong Q2 Earnings, Surpassing Analyst Estimates Wintrust Financial Corporation (NASDAQ:WTFC) reported Q2 earnings that significantly surpassed analyst expectations. The company achieved substantial year-over-year growth in bo
Datadog (NASDAQ: DDOG) Stock Analysis: AI Infrastructure Monitoring and Future Growth Datadog's Strong Performance : The company has seen significant stock growth, surging approximately 94% this year , driven by its critical role in monitoring artificial intelligence (AI) infrast
Citigroup initiated an "Underperform" rating on Annexon (NASDAQ: ANNX) , citing inherent risks despite the company's promising biopharmaceutical pipeline. Annexon is advancing treatments for neuroinflammatory diseases, including vonaprument for geographic atrophy and tanruprubart
Zions Bancorporation (NASDAQ: ZION) delivered a strong Q2 2026 financial performance , significantly surpassing market expectations. The company reported an impressive earnings per share (EPS) of $3.05 , well above analyst estimates, driven by net earnings of $452 million . Reven
Morgan Stanley downgraded Intuit to "Equalweight" with a $335.00 price target, signaling a cautious outlook despite potential upside. Intuit faces challenges in its do-it-yourself (DIY) tax business , losing lower-income customers due to pricing, and plans to introduce more compe
Lexington Realty Trust (NYSE: LXP) , a prominent industrial real estate investment trust (REIT), owns a vast portfolio of modern warehouses and logistics properties across the U.S. The company's stock was downgraded by Citigroup (NYSE: C) from "Outperform" to "Perform" following
ServisFirst Bancshares (NYSE: SFBS) reported earnings per share (EPS) of $1.57 , meeting analyst estimates and marking a significant 40% increase year-over-year. The regional bank achieved robust revenues of $168.53 million , surpassing consensus forecasts and demonstrating 19.8%
Calix (NYSE: CALX) reported an impressive earnings per share (EPS) of $0.47 , significantly beating the consensus estimate of $0.40 by 17.50% . The company demonstrated strong revenue performance , posting $293.33 million for the quarter, surpassing estimates by 1.20% and showing
Steel Dynamics (NASDAQ:STLD) reported an impressive earnings per share (EPS) of $3.69 , significantly surpassing analyst estimates for Q2 2026. The company achieved robust total sales of $6.1 billion , exceeding expectations and driven by strong steel pricing . Operational streng
Ryanair (NASDAQ: RYAAY) missed Q2 analyst forecasts for both earnings per share and revenue, indicating a challenging quarter for the low-cost airline. The company experienced a significant profit decline of 34% , primarily driven by a doubling in unhedged fuel prices and a 6% de
Analyst firm BMO Capital has set a new, higher price target for Axsome Therapeutics, reflecting strong confidence and significant growth potential for the stock. The U.S. Food and Drug Administration (FDA) has accepted Axsome's New Drug Application for AXS-12, a key regulatory mi
Goldman Sachs (NYSE:GS) received an upgrade to Hold from HSBC, signaling a more neutral analyst outlook for the investment banking giant. The global financial institution reported record second-quarter results, surpassing both revenue and earnings expectations due to strong inves
AMC Entertainment Holdings (NYSE: AMC) reported a surprise profit with adjusted earnings per share (EPS) of $0.14 , significantly beating analyst expectations. The company achieved record revenue of $1.60 billion , marking a 14.2% increase year-over-year. Operational improvements
Insmed (NASDAQ: INSM) received an "Outperform" rating and a $192.00 price target from BMO Capital, indicating a potential 79.41% upside. The company's PAH treatment, TPIP, showed positive 12-month clinical data with sustained patient improvement and a strong safety profile. Insti
Analyst Confidence: Financial firm BMO Capital initiated "Outperform" coverage on Axsome Therapeutics, citing strong drug pipeline progress and market potential. Regulatory Milestones: The U.S. Food and Drug Administration (FDA) accepted Axsome Therapeutics' New Drug Application
Headlines provided by Investing.com